Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to Fluoroquinolones and linezolid

被引:100
作者
Escribano, I.
Rodriguez, C.
Llorca, B.
Garcia-Pachon, E.
Ruiz, M.
Royo, G.
机构
[1] Hosp Gen Univ Elche, Microbiol Sect, ES-03203 Elche, Spain
[2] Univ Miguel Hernandez, Hosp Gen Univ Elche, Sect Pneumol, ES-03203 Elche, Spain
关键词
Mycobacterium tuberculosis; fluoroquinolones; efflux pumps; linezolid; drug resistance; IN-VITRO ACTIVITY; QUINOLONE RESISTANCE; SUSCEPTIBILITY; LEVOFLOXACIN; OFLOXACIN; MUTANTS; CLONING; GYRASE;
D O I
10.1159/000109769
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Our aim was to study the influence of efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Methods: We studied the mutations in gyrA and gyrB genes and the influence of efflux pump systems with 2 inhibitors ( reserpine and MC 207.110). Results: The effect of the active efflux system on the decrease in sensitivity to ciprofloxacin, moxifloxacin, levofloxacin, ofloxacin, gatifloxacin and linezolid was studied by investigating the variation in the in vitro activity of these compounds when assayed in association with reserpine and MC 207.110. These inhibitors exhibit activity both in strains that are resistant and in strains that are susceptible to these antibiotics. However, they are seen to be most active in resistant strains, since the minimum inhibitory concentration of the antibiotics studied in these strains was reduced between 2- and 6- fold. Conclusions: Therefore, these mechanisms are involved in the resistance to both compounds. It would be of interest to carry out further studies to determine to what extent these active efflux systems influence resistance to the different groups of drugs used in the treatment of tuberculosis, with a view to the possibility of using the inhibitors of these systems in future therapeutic applications.
引用
收藏
页码:397 / 401
页数:5
相关论文
共 50 条
  • [31] Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips
    Antonova, O. V.
    Gryadunov, D. A.
    Lapa, S. A.
    Kuz'min, A. V.
    Larionova, E. E.
    Smirnova, T. G.
    Nosova, E. Yu.
    Skotnikova, O. I.
    Chernousova, L. N.
    Moroz, A. M.
    Zasedatelev, A. S.
    Mikhailovich, V. M.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 145 (01) : 108 - 113
  • [32] Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips
    O. V. Antonova
    D. A. Gryadunov
    S. A. Lapa
    A. V. Kuz’min
    E. E. Larionova
    T. G. Smirnova
    E. Yu. Nosova
    O. I. Skotnikova
    L. N. Chernousova
    A. M. Moroz
    A. S. Zasedatelev
    V. M. Mikhailovich
    Bulletin of Experimental Biology and Medicine, 2008, 145 : 108 - 113
  • [33] THE NATURE OF GENOTYPIC RESISTANCE TO FLUOROQUINOLONES IN MYCOBACTERIUM TUBERCULOSIS CIRCULATING IN RUSSIAN FEDERATION
    Andreevskaya, S. N.
    Smirnova, T. G.
    Chernousova, L. N.
    Larionova, E. E.
    Kiseleva, E. A.
    Ergeshov, A.
    BULLETIN OF RUSSIAN STATE MEDICAL UNIVERSITY, 2022, (05): : 15 - 22
  • [34] High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan
    Chien, Jung-Yien
    Yu, Chong-Jen
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (03) : 491 - 495
  • [35] Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India
    Narang, Anshika
    Garima, Kushal
    Porwal, Shraddha
    Bhandekar, Archana
    Shrivastava, Kamal
    Giri, Astha
    Sharma, Naresh Kumar
    Bose, Mridula
    Varma-Basil, Mandira
    PLOS ONE, 2019, 14 (09):
  • [36] Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates
    Li, Guilian
    Zhang, Jingrui
    Guo, Qian
    Wei, Jianhao
    Jiang, Yi
    Zhao, Xiuqin
    Zhao, Li-li
    Liu, Zhiguang
    Lu, Jianxin
    Wan, Kanglin
    JOURNAL OF ANTIBIOTICS, 2015, 68 (07) : 431 - 435
  • [37] Mycobacterium tuberculosis Isolate with a Distinct Genomic Identity Overexpresses a Tap-Like Efflux Pump
    N. Siddiqi
    R. Das
    N. Pathak
    S. Banerjee
    N. Ahmed
    V. M. Katoch
    S. E. Hasnain
    Infection, 2004, 32 : 109 - 111
  • [38] Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
    Shen, Gwan-Han
    Tsao, Thomas Chang-Yao
    Kao, Shang-Jyh
    Lee, Jen-Jyh
    Chen, Yen-Hsu
    Hsieh, Wei-Chung
    Hsu, Gwo-Jong
    Hsu, Yen-Tao
    Huang, Ching-Tai
    Lau, Yeu-Jun
    Tsao, Shih-Ming
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (03) : 201 - 205
  • [39] In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis
    Rodríguez, JC
    Ruiz, M
    Climent, A
    Royo, G
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (03) : 229 - 231
  • [40] Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India
    Desikan, Prabha
    Panwalkar, Nikita
    Chaudhuri, Shreya
    Khan, Zeba
    Punde, Ram Prakash
    Pauranik, Ankur
    Mirza, Shaina Beg
    Ranjan, Rajeev
    Anand, Sridhar
    Sachdeva, K. S.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2020, 114 (04) : 249 - 254